Medication info
Escarb Tablets 60/2.5 mg

Escarb Tablets 60/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Yellow, rounded square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300055 · Approved 2023.01.05 · Insurance code 657308780

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended to adjust the dose of fimasartan before administering this medicine; however, if blood pressure is not controlled as follows, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is necessary in elderly patients 70 years of age or younger. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy in pediatric and adolescent patients 18 years of age or younger have not been established.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is used to lower blood pressure, but additional treatment may be needed for patients with essential hypertension who do not achieve sufficient blood pressure control on monotherapy. In such cases, blood pressure can be managed more effectively by combining it with other medications. Therefore, Pimasartan potassium is used to improve blood pressure control in essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended to adjust the dose of fimasartan before administering this medicine; however, if blood pressure is not controlled as follows, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is necessary in elderly patients 70 years of age or younger. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy in pediatric and adolescent patients 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to this medication's active substance or related components, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with moderate to severe liver impairment, patients with biliary obstruction, patients with certain diabetes and kidney diseases should not take this medication. Patients with low blood volume or salt, patients with impaired kidney function, patients with renovascular hypertension, patients with heart valve disease, patients with severe hypotension, elderly individuals, and others should exercise special caution when using this medication. This medication may cause side effects such as dizziness, headache, edema, urinary disorders, insomnia, and flushing, and in rare cases, serious adverse reactions have been reported, so medical consultation should be sought immediately if any unusual symptoms occur. This medication lowers blood pressure, so patients with hypotension or electrolyte imbalances should correct their condition before taking it and monitor their condition closely during treatment. Additionally, due to the risk of hyperkalemia, it is recommended to periodically check serum potassium levels. This medication may interact with other antihypertensive agents, diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so if you are taking other medications, be sure to inform your healthcare provider. Pregnant women or those planning to become pregnant should avoid taking this medication, and women who are breastfeeding should preferably stop breastfeeding or discontinue this medication while taking it. Safety and efficacy in children and adolescents under 18 years of age have not been established. No special dosage adjustment is needed for elderly patients; however, some elderly individuals may be more sensitive to this medication, so caution is required. Patients with moderate to severe liver impairment should not take this medication. In case of overdose, symptoms such as hypotension, palpitations, and reflex tachycardia may occur; in such cases, immediate medical attention should be sought. This medication should be kept out of reach of children, and transferring to another container may compromise the quality, so care should be taken.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urination disorder
  • insomnia
  • flushing
  • syncope
  • sedation
Show 162 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • low back pain
  • limb pain
  • fatigue
  • fever
  • neck/shoulder pain
  • fracture
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • nosebleed
  • bronchitis
  • sensory abnormalities
  • numbness
  • tremor
  • hypertonia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional bowel disorder
  • gastroenteritis
  • frequency of urination
  • difficulty urinating
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • benign prostatic hyperplasia
  • scrotal pain
  • blood pressure fluctuations
  • fatty liver
  • postoperative pain
  • allergy
  • chills
  • nasal polyps
  • edema
  • alopecia
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tension hyperreflexia
  • sensory reduction
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal dysfunction
  • change in bowel habits
  • dry mouth
  • gingival hyperplasia
  • pancreatitis
  • hyperglycemia
  • malaise
  • pain
  • weight gain/loss
  • vasculitis
  • dyspnea
  • gynecomastia
  • angioedema
  • polymorphic erythema
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • loose stools
  • erythematous skin lesions
  • papular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • frailty
  • abdominal vascular swelling
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is best to store the medication at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Yellow, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.